307 related articles for article (PubMed ID: 36902478)
1. The Functions of TRIM56 in Antiviral Innate Immunity and Tumorigenesis.
Fu L; Zhou X; Jiao Q; Chen X
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902478
[TBL] [Abstract][Full Text] [Related]
2. Impaired Antiviral Responses to Extracellular Double-Stranded RNA and Cytosolic DNA, but Not to Interferon-α Stimulation, in TRIM56-Deficient Cells.
Wang D; Wang R; Li K
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062293
[TBL] [Abstract][Full Text] [Related]
3. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
[TBL] [Abstract][Full Text] [Related]
4. The E3 ligase TRIM56 is a host restriction factor of Zika virus and depends on its RNA-binding activity but not miRNA regulation, for antiviral function.
Yang D; Li NL; Wei D; Liu B; Guo F; Elbahesh H; Zhang Y; Zhou Z; Chen GY; Li K
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007537. PubMed ID: 31251739
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of the antiviral properties of TRIM56: a potential therapeutic intervention for COVID-19.
Heidary F; Gharebaghi R
Expert Rev Clin Immunol; 2020 Oct; 16(10):973-984. PubMed ID: 32903131
[TBL] [Abstract][Full Text] [Related]
6. Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.
Liu B; Li NL; Wang J; Shi PY; Wang T; Miller MA; Li K
J Virol; 2014 Dec; 88(23):13821-35. PubMed ID: 25253338
[TBL] [Abstract][Full Text] [Related]
7. TRIM56 is a virus- and interferon-inducible E3 ubiquitin ligase that restricts pestivirus infection.
Wang J; Liu B; Wang N; Lee YM; Liu C; Li K
J Virol; 2011 Apr; 85(8):3733-45. PubMed ID: 21289118
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA.
Tsuchida T; Zou J; Saitoh T; Kumar H; Abe T; Matsuura Y; Kawai T; Akira S
Immunity; 2010 Nov; 33(5):765-76. PubMed ID: 21074459
[TBL] [Abstract][Full Text] [Related]
9. TRIM56-mediated production of type I interferon inhibits intracellular replication of
Cheng R; Zhou C; Zhao M; Zhang S; Wan W; Yu Y; Wen B; Jiao J; Xiong X; Xu Q; OuYang X
Microbiol Spectr; 2024 Apr; 12(4):e0369523. PubMed ID: 38358243
[TBL] [Abstract][Full Text] [Related]
10. TRIM56: a promising prognostic immune biomarker for glioma revealed by pan-cancer and single-cell analysis.
Wang B; Wang Z; Li Y; Shang Z; Liu Z; Fan H; Zhan R; Xin T
Front Immunol; 2024; 15():1327898. PubMed ID: 38348047
[TBL] [Abstract][Full Text] [Related]
11. TRIM56 is an essential component of the TLR3 antiviral signaling pathway.
Shen Y; Li NL; Wang J; Liu B; Lester S; Li K
J Biol Chem; 2012 Oct; 287(43):36404-13. PubMed ID: 22948160
[TBL] [Abstract][Full Text] [Related]
12. TRIM56-mediated monoubiquitination of cGAS for cytosolic DNA sensing.
Seo GJ; Kim C; Shin WJ; Sklan EH; Eoh H; Jung JU
Nat Commun; 2018 Feb; 9(1):613. PubMed ID: 29426904
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the recognition and degradation of host TRIM proteins by Salmonella effector SopA.
Fiskin E; Bhogaraju S; Herhaus L; Kalayil S; Hahn M; Dikic I
Nat Commun; 2017 Jan; 8():14004. PubMed ID: 28084320
[TBL] [Abstract][Full Text] [Related]
14. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
Zhao L; Zhang P; Su XJ; Zhang B
J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
[TBL] [Abstract][Full Text] [Related]
16. TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein.
Yang X; Zhang Y; Xue Z; Hu Y; Zhou W; Xue Z; Liu X; Liu G; Li W; Liu X; Li X; Han M; Wang J
J Exp Clin Cancer Res; 2022 Dec; 41(1):336. PubMed ID: 36471347
[TBL] [Abstract][Full Text] [Related]
17. TRIM56 Suppresses Multiple Myeloma Progression by Activating TLR3/TRIF Signaling.
Chen Y; Zhao J; Li D; Hao J; He P; Wang H; Zhang M
Yonsei Med J; 2018 Jan; 59(1):43-50. PubMed ID: 29214775
[TBL] [Abstract][Full Text] [Related]
18. To TRIM the Immunity: From Innate to Adaptive Immunity.
Yang W; Gu Z; Zhang H; Hu H
Front Immunol; 2020; 11():02157. PubMed ID: 33117334
[TBL] [Abstract][Full Text] [Related]
19. TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense.
Wang L; Ning S
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670221
[TBL] [Abstract][Full Text] [Related]
20. TRIM56 suppresses the malignant development of hepatocellular carcinoma via targeting RBM24 and inactivating the Wnt signaling.
Yang Y; Mao FF; Guo L; Guo WX
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):722-730. PubMed ID: 33577026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
